You are here
Dr. Andrew Ko did his undergraduate studies at Brown University in Providence, Rhode Island, graduating with honors in Applied Mathematics and Biology, and then received his medical degree at the Johns Hopkins School of Medicine. He went on to complete residency training in Internal Medicine at Beth Israel Hospital/Harvard Medical School, and a fellowship in Medical Oncology at Stanford University Medical Center. He is currently a Professor of Clinical Medicine in the Division of Hematology/Oncology at the University of California San Francisco.
Dr. Ko’s primary clinical and research interests focus on gastrointestinal malignancies, where he has led and been involved in the development and evaluation of new therapeutic agents ranging from novel cytotoxics to molecularly targeted agents to immunotherapies, with a particular emphasis on pancreatic and gastroesophageal cancers. His interests include identifying individual patient/tumor characteristics that influence prognosis and response to specific therapies, including both tissue- and blood-based biomarkers.
At UCSF, Dr. Ko chairs the Cancer Center scientific Protocol Review Committee and the Gastrointestinal Cancer site committee. Nationally, he is actively involved in the American Society of Clinical Oncology (ASCO), where he has served on the scientific program and grants review committees; serves as Associate Editor for Gastrointestinal Oncology for the Journal of Clinical Oncology; and is a member of the NCI Pancreatic Cancer Task Force, the Alliance for Clinical Trials in Oncology cooperative group, and the National Comprehensive Cancer Network (NCCN) Pancreatic Cancer guidelines committee.
Andrew has been married for 14 years to his wife, Christine, a civil engineer. They have two children, Naomi (11) and Elliott (7). Outside of work, he enjoys playing the piano, running, hiking, playing and watching sports, whitewater rafting, reading, cooking, and singing.